Seeing Is Believing
Freeline Therapeutics Holdings Plc's activity chart (see below) currently has 15 price targets and 22 ratings on display.
Analysts average stock forecasts to be materialized ratio is 57.33% with an average time for these price targets to be met of 128.8 days.
Most recent stock forecast was given by PATRICK TRUCCHIO from HC WAINWRIGHT on 28-Nov-2023. First documented stock forecast 01-Sep-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-May-2021
$6.5
$0.02 (0.31%)
$15
Buy Since 01-Sep-2020
$5
$-1.48 (-22.84%)
$5
Hold Since 01-Jun-2023
$4
$-2.48 (-38.27%)
Buy Since 01-Feb-2022
$30
$23.52 (362.96%)
What is FRLN (Freeline Therapeutics Holdings Plc) average time for price targets to be met?
Which analyst has the current highest performing score on FRLN (Freeline Therapeutics Holdings Plc) with a proven track record?
Which analyst has the most public recommendations on FRLN (Freeline Therapeutics Holdings Plc)?
Which analyst is the currently most bullish on FRLN (Freeline Therapeutics Holdings Plc)?
Which analyst is the currently most reserved on FRLN (Freeline Therapeutics Holdings Plc)?